Company
Shattuck Labs, Inc. (STTK)
Standardized SEC financial data for Shattuck Labs, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001680367 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
-82.5%
Return on equity
-59.2%
Free cash flow
-$40.0M
Current ratio
11.70×
EPS (diluted)
$-0.70
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $30.0M | $652K | $1.7M | $5.7M | $1.0M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $335.4M | $268.8M | $161.3M | $130.6M | $73.0M | $78.1M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$33.7M | -$57.1M | -$94.5M | -$81.2M | -$60.5M | -$39.9M |
| Capital expenditures |
Get STTK data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/STTK/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/STTK/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"